Authors
Loading...
This evaluation reveals that combining particle therapy with PD-1 inhibitors significantly enhances response rates in mismatch repair proficient rectal cancer, suggesting new therapeutic avenues.
Cameron M. Callaghan (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: